JPWO2019133608A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2019133608A5 JPWO2019133608A5 JP2020535579A JP2020535579A JPWO2019133608A5 JP WO2019133608 A5 JPWO2019133608 A5 JP WO2019133608A5 JP 2020535579 A JP2020535579 A JP 2020535579A JP 2020535579 A JP2020535579 A JP 2020535579A JP WO2019133608 A5 JPWO2019133608 A5 JP WO2019133608A5
- Authority
- JP
- Japan
- Prior art keywords
- electrode
- electric field
- field energy
- additional
- pulsed electric
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Description
いくつかの実施形態では、不整脈を治療するために、通路は心臓内に設けられ、機能上連続的な治療区域は肺静脈と左心房との間に電気的切断を含む。任意選択的に、通路は肺静脈を含む。いくつかの実施形態では、機能上連続的な治療区域は、貫壁性病変を含む。他の実施形態では、通路は肺内に気道を含み、機能上連続的な治療区域は、気道の軟骨層を維持しながら、細胞型の空孔を作り出す。いくつかの実施形態では、細胞型は、上皮細胞、杯状細胞及び/又は粘膜下腺細胞を含む。いくつかの実施形態では、機能上連続的な治療区域は、最大2.5cmまで且つこれを超えない深度を有する。 In some embodiments, a passageway is provided in the heart to treat an arrhythmia and the functionally continuous treatment segment includes an electrical disconnection between the pulmonary veins and the left atrium. Optionally, the passageway includes pulmonary veins. In some embodiments, the functionally continuous treatment area comprises a transmural lesion. In other embodiments, the passageway comprises an airway within the lung, and the functionally continuous treatment zone creates a cell-type void while maintaining the cartilaginous lining of the airway. In some embodiments, the cell types comprise epithelial cells, goblet cells and/or submucosal gland cells. In some embodiments, the functionally continuous treatment zone has a depth of up to and not exceeding 2.5 cm.
いくつかの実施形態では、通路は心臓内に設けられ、カテーテルの遠位端部は心臓内に位置決めされるように構成されるとともに、少なくとも1つのエネルギー送達アルゴリズムは、不整脈を治療するために機能上連続的な治療区域に肺静脈と左心房との間に電気的切断を含むようにさせる信号パラメータを含む。任意選択的に、通路は肺静脈を含み、カテーテルの遠位端部は肺静脈内に位置決めされるように構成されている。いくつかの実施形態では、信号パラメータは機能上連続的な治療区域に貫壁性病変を含むようにさせる。 In some embodiments, the passageway is provided within the heart, the distal end of the catheter is configured to be positioned within the heart, and the at least one energy delivery algorithm functions to treat an arrhythmia. Contains signal parameters that cause the continuous treatment segment to include electrical disconnection between the pulmonary veins and the left atrium. Optionally, the passageway includes a pulmonary vein and the distal end of the catheter is configured to be positioned within the pulmonary vein. In some embodiments, the signal parameters cause the functionally continuous treatment area to include transmural lesions.
PV-LA導通再開の推定される理由は、アブレーションライン内のギャップ及び/又は経壁病変生成の失敗である。ラインのギャップは、PVからLAへの電気的活動の再開を可能にし、PVトリガに心房細動を再度開始させるとともに、他のマイクロリエントラント心房性不整脈のトリガとしてもまた機能する場合がある。同様に、可逆的な心房損傷は、不完全な病変形成に起因する場合があり、一時的な電気的結合解除を生じるが、細胞死は生じない。線状病変全体にわたる永続的な導通遮断は、細胞死を伴う貫壁性病変を必要とし、且つ/又は使用する。前述したように、本開示の専用のカテーテル設計、別個のエネルギー送達アルゴリズム、及び使用方法は、周方向のアブレーションの規則性の向上を提供する。これにより、アブレーションライン内の導通ギャップが減少する。加えて、本開示の専用のカテーテル設計、別個のエネルギー送達アルゴリズム、及び使用方法は、貫壁性病変を形成する能力を高めることが可能である。このような改良は、心房細動を治療する際に有益な場合があるとともに、肺通路、胃腸の通路、並びに、身体内の他の自然通路及び人工通路を含む、多種多様な他の症状及び/又は他の体腔を治療する際に有用な場合がある。 Probable reasons for PV-LA continuity resumption are gaps in the ablation line and/or failure to create a transmural lesion. The line gap allows resumption of electrical activity from the PV to the LA, causing the PV trigger to re-initiate atrial fibrillation and may also serve as a trigger for other micro-reentrant atrial arrhythmias. Similarly, reversible atrial injury may result from incomplete lesion formation, resulting in transient electrical decoupling but not cell death. A permanent conduction block across a linear lesion requires and/or uses a transmural lesion with cell death. As previously described, the specialized catheter design, separate energy delivery algorithms, and methods of use of the present disclosure provide improved regularity of circumferential ablation. This reduces the conduction gaps in the ablation line. Additionally, the specialized catheter design, discrete energy delivery algorithms, and methods of use of the present disclosure can enhance the ability to form transmural lesions. Such improvements may be beneficial in treating atrial fibrillation, as well as in a wide variety of other conditions and conditions, including pulmonary passageways, gastrointestinal passageways, and other natural and artificial passageways within the body. /or may be useful in treating other body cavities.
図8に示されているように、エネルギーの限局的送達を多種多様なやり方で利用して、組織への効果を向上及び/又は最大化することができる。特に、電極(例えば212a、212b、212c、212d)へのエネルギー送達の正確なタイミング及び順番付けを利用して、以下でさらに説明するように、エネルギーを受け取る組織内の細胞死を確実にすることができる。これは、心房細動の治療に特に有用な場合がある。前述したように、線状病変全体にわたる永続的な導通遮断は、一時的な可逆的効果ではなく、細胞死を伴う貫壁性病変を使用し、且つ/又は必要とする。いくつかの実施形態では、PEF波形は、ナノ秒からマイクロ秒のパルス持続時間を反映する周波数を有する双極性の相殺を用いて、麻痺者の有無にかかわらず、細胞及び細胞小器官膜の両方を不安定化させる能力を保持しながら、全身性の筋収縮の程度を容認可能な低レベルまで軽減するものである。これは、ナノ秒のパルス電界(nsPEF)又は従来のミリ秒の不可逆的電気穿孔(IRE)法のいずれかを用いて到達したものを超える、一意的に治療結果を強化する素因となる細胞に及ぼす色々な形態の効果を誘発する。したがって、送達されるエネルギーは、標的組織で十分に大きく、且つ効果的な治療ゾーンを誘発することができるが、これは、nsPEFにとっての課題であり、一方、有利な安全性及び筋収縮プロファイルを維持することは、従来のミリ秒のIREにとっての、特に、外部の分散パッドを使用する単極パルス送達構成にとっての課題である。 As shown in FIG. 8, localized delivery of energy can be utilized in a wide variety of ways to enhance and/or maximize tissue effects. In particular, utilizing precise timing and sequencing of energy delivery to the electrodes (e.g., 212a, 212b, 212c, 212d) to ensure cell death within the tissue receiving the energy, as further described below. can be done. This may be particularly useful in treating atrial fibrillation. As noted above, permanent conduction block across linear lesions uses and/or requires transmural lesions with cell death rather than transient reversible effects. In some embodiments, PEF waveforms are applied to both cell and organelle membranes with and without paralysis using bipolar cancellation with frequencies reflecting pulse durations from nanoseconds to microseconds. It reduces the degree of generalized muscle contraction to an acceptably low level while retaining the ability to destabilize the . This predisposes cells to uniquely enhance therapeutic outcomes beyond those reached using either nanosecond pulsed electric fields (nsPEF) or conventional millisecond irreversible electroporation (IRE) methods. trigger various forms of effects. Thus, the delivered energy can induce a sufficiently large and effective treatment zone at the target tissue, which is a challenge for nsPEF, while providing favorable safety and muscle contraction profiles. Sustainability is a challenge for conventional millisecond IREs, especially for unipolar pulse delivery configurations that use external dispersive pads.
Claims (46)
電極が前記通路の前記内側周面の一部にわたるように、前記通路内に前記電極を位置決めすることと、
前記電極にパルス電界エネルギーを供給することによって、前記通路の前記内側周面の第1の部分に沿って第1の治療区域を作り出すことと、
前記電極が再位置決めされるごとに前記電極が前記内側周面の追加の部分にわたるように、前記電極を前記通路内に1回又は複数回前記通路内に再位置決めすることと、
前記電極が再位置決めされるごとに前記再位置決めされた電極にパルス電界エネルギーを供給することによって、前記通路の前記内側周面の各追加の部分に沿って追加の治療区域を作り出すことと、
を含み、
前記第1の部分及び各追加の部分は、前記内側周面にわたる、治療効果の観点で機能的に連続している治療区域を作り出すように前記内側周面に沿って延在する、方法。 A method performed by a system for treating a passageway in the body having an inner perimeter, comprising:
positioning the electrode within the passage such that the electrode spans a portion of the inner perimeter of the passage;
creating a first treatment zone along a first portion of the inner perimeter of the passageway by supplying pulsed electric field energy to the electrode;
repositioning the electrode within the passageway one or more times such that the electrode spans an additional portion of the inner perimeter each time the electrode is repositioned;
creating additional treatment zones along each additional portion of the inner circumference of the passageway by supplying pulsed electric field energy to the repositioned electrodes each time the electrodes are repositioned;
including
The method of claim 1, wherein the first portion and each additional portion extend along the inner circumferential surface to create a treatment zone across the inner circumferential surface that is functionally continuous in terms of therapeutic efficacy .
カテーテルであって、前記カテーテルの遠位端部の付近に設けられた第1の電極及び前記カテーテルの遠位端部の付近に設けられた少なくとも1つの追加の電極を含み、前記第1の電極及び前記少なくとも1つの追加の電極が、パルス電界エネルギーを前記通路の単一の内側周面に伝送するために整列されるように、前記カテーテルの前記遠位端部が前記通路内に位置決めされるように構成された、カテーテルと、
前記第1の電極及び前記少なくとも1つの追加の電極と電気的に通信するジェネレータであって、
a)前記第1の電極を通るエネルギー送達に優先順位をつけるように、前記パルス電界エネルギーの電気信号を前記第1の電極に供給して、第1の治療区域を作り出し、
b)電気信号が供給されたときに前記少なくとも1つの追加の電極のそれぞれを通るエネルギー送達に優先順位をつけるように、前記パルス電界エネルギーの前記電気信号を前記少なくとも1つの追加の電極のそれぞれに個々に供給するように切り替えて、前記少なくとも1つの追加の電極のそれぞれに対応する追加の治療区域を作り出すようにする、
少なくとも1つのエネルギー送達アルゴリズムを含む前記ジェネレータと、
を含み、
前記第1の治療区域及び前記追加の治療区域は、前記単一の内側周面にわたる、治療効果の観点で機能的に連続している治療区域を作り出すように、前記通路の前記単一の内側周面に沿って延在する、システム。 A system for treating a passageway in the body, comprising:
a catheter comprising a first electrode near a distal end of said catheter and at least one additional electrode near a distal end of said catheter, said first electrode and the at least one additional electrode is positioned within the passageway such that the distal end of the catheter is aligned to transmit pulsed electric field energy to a single inner circumferential surface of the passageway. a catheter configured to;
a generator in electrical communication with the first electrode and the at least one additional electrode,
a) supplying an electrical signal of said pulsed electric field energy to said first electrode to prioritize energy delivery through said first electrode to create a first treatment zone;
b) directing said electrical signal of said pulsed electric field energy to each of said at least one additional electrode so as to prioritize energy delivery through each of said at least one additional electrode when the electrical signal is applied; switching to individual delivery to create additional treatment areas corresponding to each of the at least one additional electrode;
the generator including at least one energy delivery algorithm;
including
The first treatment zone and the additional treatment zone are arranged inside the single interior of the passageway to create a treatment zone that spans the single inner perimeter and is functionally continuous in terms of therapeutic efficacy. A system extending along the perimeter.
前記少なくとも1つのエネルギー送達アルゴリズムは、不整脈を治療するために、治療効果の観点で機能的に連続している前記治療区域に肺静脈と左心房との間に電気的切断を含むようにさせる信号パラメータを含む、請求項2に記載のシステム。 the passageway is provided within the heart, the distal end of the catheter is configured to be positioned within the heart;
The at least one energy delivery algorithm causes the treatment area that is functionally continuous in terms of therapeutic efficacy to include electrical disconnection between the pulmonary veins and the left atrium to treat an arrhythmia. 3. The system of claim 2, including parameters.
前記少なくとも1つのエネルギー送達アルゴリズムは、治療効果の観点で機能的に連続している前記治療区域に、前記気道の軟骨層を維持しながら、細胞の空孔を含むようにさせる信号パラメータを含む、請求項2に記載のシステム。 the passageway includes an airway of the lung , the distal end of the catheter being configured to be positioned within the airway;
The at least one energy delivery algorithm includes signal parameters that cause the treatment area to be functionally continuous in terms of therapeutic efficacy to contain cellular voids while maintaining the cartilage layer of the airway . 3. The system of claim 2.
前記メンテナンスパルス電界エネルギーは、前記パルス電界エネルギーよりも低い電圧を有する、請求項21に記載のシステム。 said at least one energy delivery algorithm supplying maintenance pulse electric field energy to said first electrode and/or said at least one additional electrode between stages;
22. The system of claim 21, wherein said maintenance pulse electric field energy has a lower voltage than said pulse electric field energy.
前記バスケット形状の一部は、絶縁されている、請求項2~24のいずれか一項に記載のシステム。 said at least first electrode and said at least one additional electrode comprising a plurality of wires or ribbons forming an electrode delivery body having an expandable basket shape;
A system according to any one of claims 2 to 24, wherein said basket-shaped part is insulated.
カテーテルであって、前記カテーテルの遠位端部の付近に設けられた少なくとも1つの電極を含み、前記少なくとも1つの電極がパルス電界エネルギーを前記通路の内側表面に伝送することができるように、前記カテーテルの前記遠位端部が前記通路内に位置決めされるように構成された、カテーテルと、
前記少なくとも1つの電極と電気的に通信するジェネレータであって、パルス電界エネルギーが前記通路の前記内側表面上の細胞に送達されるように、前記少なくとも1つの電極に電気信号を供給する、少なくとも1つのエネルギー送達アルゴリズムを含む前記ジェネレータと、
を含み、
前記電気信号は複数のパケットを含み、
各パケットは複数の二相のサイクルを含み、且つ、
各パケットは0.0001~10秒で時間的に離隔されている、システム。 A system for treating a passageway in the body, comprising:
a catheter comprising at least one electrode located near a distal end of said catheter, said at least one electrode being capable of transmitting pulsed electric field energy to an inner surface of said passage; a catheter configured such that the distal end of the catheter is positioned within the passageway;
at least one generator in electrical communication with the at least one electrode for providing an electrical signal to the at least one electrode such that pulsed electric field energy is delivered to cells on the inner surface of the passageway; the generator including one energy delivery algorithm;
including
the electrical signal includes a plurality of packets;
each packet includes a plurality of biphasic cycles, and
Each packet is separated in time by 0.0001 to 10 seconds, system.
前記メンテナンスパルス電界エネルギーは、前記パルス電界エネルギーよりも低い電圧を有する、請求項35に記載のシステム。 said at least one energy delivery algorithm delivering maintenance pulse electric field energy to said first electrode and/or said at least one additional electrode between packets;
36. The system of claim 35, wherein said maintenance pulse electric field energy has a lower voltage than said pulse electric field energy.
前記ジェネレータは、前記心臓信号と同期して前記メンテナンスパルス電界エネルギーを供給する、請求項38に記載のシステム。 further comprising a cardiac monitor configured to acquire a cardiac signal of the patient;
39. The system of Claim 38, wherein the generator provides the maintenance pulse electric field energy synchronously with the cardiac signal.
前記バスケット形状の一部は、絶縁されている、請求項35~40のいずれか一項に記載のシステム。 said at least first electrode and said at least one additional electrode comprising a plurality of wires or ribbons forming an electrode delivery body having an expandable basket shape;
The system of any one of claims 35-40, wherein said basket-shaped portion is insulated.
前記ジェネレータは、前記心臓信号と同期して前記電気信号を供給する、請求項27~43のいずれか一項に記載のシステム。 further comprising a cardiac monitor configured to acquire a cardiac signal of the patient ;
The system of any one of claims 27-43, wherein the generator provides the electrical signal synchronously with the cardiac signal.
前記通路内に複数の電極を位置決めし、前記複数の電極が前記通路の前記内側周面の少なくとも一部分にわたるようにすることと、
前記複数の電極のうちの少なくとも1つにパルス電界エネルギーを供給することによって前記通路の前記内側周面の第1の部分に沿って第1の治療区域を作り出すことであって、前記複数の電極のうちの前記少なくとも1つを通る前記第1の治療区域へのエネルギー送達に優先順位をつける、ことと、
前記複数の電極のうちの少なくとも1つにパルス電界エネルギーを供給することによって前記通路の前記内側周面の少なくとも1つの追加の部分に沿って少なくとも1つの追加の治療区域を作り出すことであって、前記複数の電極のうちの前記少なくとも1つを通る前記少なくとも1つの追加の治療区域へのエネルギー送達に優先順位をつける、ことと、
を含み、
前記第1の部分及び前記少なくとも1つの追加の部分は、前記内側周面に伝達されるエネルギーの平衡が保たれた治療区域を作り出すように前記内側周面に沿って延在する、方法。 A method performed by a system for treating a passageway in the body having an inner perimeter, comprising:
positioning a plurality of electrodes within the passage such that the plurality of electrodes span at least a portion of the inner perimeter of the passage;
creating a first treatment zone along a first portion of the inner circumferential surface of the passageway by supplying pulsed electric field energy to at least one of the plurality of electrodes, the plurality of electrodes comprising: prioritizing energy delivery to the first treatment area through the at least one of;
creating at least one additional treatment zone along at least one additional portion of the inner circumferential surface of the passageway by supplying pulsed electric field energy to at least one of the plurality of electrodes; prioritizing energy delivery to the at least one additional treatment area through the at least one of the plurality of electrodes;
including
The method, wherein the first portion and the at least one additional portion extend along the inner circumferential surface to create a balanced treatment zone for energy transferred to the inner circumferential surface .
カテーテルであって、前記カテーテルの遠位端部の付近に設けられた第1の電極及び前記カテーテルの遠位端部の付近に設けられた少なくとも1つの追加の電極を含み、前記第1の電極及び前記少なくとも1つの追加の電極が、パルス電界エネルギーを前記通路の単一の内側周面に伝送するために整列されるように、前記カテーテルの前記遠位端部が前記通路内に位置決めされるように構成された、カテーテルと、
前記第1の電極及び前記少なくとも1つの追加の電極と電気的に通信するジェネレータであって、
a)前記第1の電極を通るエネルギー送達に優先順位をつけるように前記パルス電界エネルギーの電気信号を前記第1の電極に供給して、第1の治療区域を作り出し、
b)前記電気信号が供給されたときに、前記少なくとも1つの追加の電極のそれぞれを通るエネルギー送達に優先順位をつけるように、前記パルス電界エネルギーの電気信号を前記少なくとも1つの追加の電極のそれぞれに個々に供給するように切り替えて、前記少なくとも1つの追加の電極のそれぞれに対応する追加の治療区域を作り出すようにする、
少なくとも1つのエネルギー送達アルゴリズムを含む前記ジェネレータと、
を含み、
前記第1の治療区域及び前記追加の治療区域は、前記内側周面に伝達されるエネルギーの平衡が保たれた治療区域を作り出すように前記通路の前記単一の内側周面に沿って延在する、システム。 A system for treating a passageway in the body, comprising:
a catheter comprising a first electrode near a distal end of said catheter and at least one additional electrode near a distal end of said catheter, said first electrode and the at least one additional electrode is positioned within the passageway such that the distal end of the catheter is aligned to transmit pulsed electric field energy to a single inner circumferential surface of the passageway. a catheter configured to;
a generator in electrical communication with the first electrode and the at least one additional electrode,
a) supplying an electrical signal of said pulsed electric field energy to said first electrode to prioritize energy delivery through said first electrode to create a first treatment zone;
b) applying an electrical signal of said pulsed electric field energy to each of said at least one additional electrode so as to prioritize energy delivery through each of said at least one additional electrode when said electrical signal is provided; to individually supply the at least one additional electrode to create additional treatment zones corresponding to each of the at least one additional electrode;
the generator including at least one energy delivery algorithm;
including
The first treatment zone and the additional treatment zone extend along the single inner perimeter of the passageway to create a balanced treatment zone for energy transferred to the inner perimeter. do, the system.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2023135986A JP2023168331A (en) | 2017-12-26 | 2023-08-24 | Optimization of energy delivery for various applications |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762610430P | 2017-12-26 | 2017-12-26 | |
US62/610,430 | 2017-12-26 | ||
US201862693622P | 2018-07-03 | 2018-07-03 | |
US62/693,622 | 2018-07-03 | ||
PCT/US2018/067504 WO2019133608A1 (en) | 2017-12-26 | 2018-12-26 | Optimization of energy delivery for various applications |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2023135986A Division JP2023168331A (en) | 2017-12-26 | 2023-08-24 | Optimization of energy delivery for various applications |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2021508533A JP2021508533A (en) | 2021-03-11 |
JPWO2019133608A5 true JPWO2019133608A5 (en) | 2023-04-19 |
Family
ID=65036907
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020535579A Pending JP2021508533A (en) | 2017-12-26 | 2018-12-26 | Optimizing energy delivery for a variety of applications |
JP2023135986A Pending JP2023168331A (en) | 2017-12-26 | 2023-08-24 | Optimization of energy delivery for various applications |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2023135986A Pending JP2023168331A (en) | 2017-12-26 | 2023-08-24 | Optimization of energy delivery for various applications |
Country Status (8)
Country | Link |
---|---|
US (2) | US11547851B2 (en) |
EP (2) | EP4218641A1 (en) |
JP (2) | JP2021508533A (en) |
CN (1) | CN111683613A (en) |
AU (1) | AU2018397478A1 (en) |
CA (1) | CA3087183A1 (en) |
DK (1) | DK3731771T3 (en) |
WO (1) | WO2019133608A1 (en) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015192027A1 (en) | 2014-06-12 | 2015-12-17 | Iowa Approach Inc. | Method and apparatus for rapid and selective transurethral tissue ablation |
US10660702B2 (en) | 2016-01-05 | 2020-05-26 | Farapulse, Inc. | Systems, devices, and methods for focal ablation |
US10172673B2 (en) | 2016-01-05 | 2019-01-08 | Farapulse, Inc. | Systems devices, and methods for delivery of pulsed electric field ablative energy to endocardial tissue |
US20170189097A1 (en) | 2016-01-05 | 2017-07-06 | Iowa Approach Inc. | Systems, apparatuses and methods for delivery of ablative energy to tissue |
US9987081B1 (en) | 2017-04-27 | 2018-06-05 | Iowa Approach, Inc. | Systems, devices, and methods for signal generation |
EP3681391A1 (en) | 2017-09-12 | 2020-07-22 | Farapulse, Inc. | Systems, apparatuses, and methods for ventricular focal ablation |
WO2019133608A1 (en) | 2017-12-26 | 2019-07-04 | Gala Therapeutics, Inc. | Optimization of energy delivery for various applications |
EP3790483A1 (en) | 2018-05-07 | 2021-03-17 | Farapulse, Inc. | Systems, apparatuses, and methods for filtering high voltage noise induced by pulsed electric field ablation |
CN115836908A (en) | 2018-05-07 | 2023-03-24 | 波士顿科学医学有限公司 | Systems, devices, and methods for delivering ablation energy to tissue |
WO2020061359A1 (en) | 2018-09-20 | 2020-03-26 | Farapulse, Inc. | Systems, apparatuses, and methods for delivery of pulsed electric field ablative energy to endocardial tissue |
US11045628B2 (en) | 2018-12-11 | 2021-06-29 | Biosense Webster (Israel) Ltd. | Balloon catheter with high articulation |
US11850051B2 (en) | 2019-04-30 | 2023-12-26 | Biosense Webster (Israel) Ltd. | Mapping grid with high density electrode array |
US10625080B1 (en) | 2019-09-17 | 2020-04-21 | Farapulse, Inc. | Systems, apparatuses, and methods for detecting ectopic electrocardiogram signals during pulsed electric field ablation |
US11065047B2 (en) | 2019-11-20 | 2021-07-20 | Farapulse, Inc. | Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses |
US11497541B2 (en) | 2019-11-20 | 2022-11-15 | Boston Scientific Scimed, Inc. | Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses |
US10842572B1 (en) | 2019-11-25 | 2020-11-24 | Farapulse, Inc. | Methods, systems, and apparatuses for tracking ablation devices and generating lesion lines |
CN113365566A (en) | 2019-12-03 | 2021-09-07 | 圣犹达医疗用品心脏病学部门有限公司 | Electroporation system and method |
US11950930B2 (en) | 2019-12-12 | 2024-04-09 | Biosense Webster (Israel) Ltd. | Multi-dimensional acquisition of bipolar signals from a catheter |
US11517218B2 (en) | 2019-12-20 | 2022-12-06 | Biosense Webster (Israel) Ltd. | Selective graphical presentation of electrophysiological parameters |
EP4057925B1 (en) | 2020-02-28 | 2023-10-11 | St. Jude Medical, Cardiology Division, Inc. | Electrode assembly including expandable isolation member |
CN112716599A (en) * | 2020-02-28 | 2021-04-30 | 圣犹达医疗用品心脏病学部门有限公司 | Electrode assembly including expandable spacer member |
US20210267672A1 (en) * | 2020-02-28 | 2021-09-02 | St. Jude Medical, Cardiology Division, Inc. | Electrode assembly including expandable isolation member |
WO2021181231A2 (en) * | 2020-03-07 | 2021-09-16 | Arga' Medtech Sa | Ablation equipment for delivering non-thermal energy to treat target regions of tissue in organs and control method thereof |
WO2021207385A1 (en) * | 2020-04-08 | 2021-10-14 | Galary, Inc. | Pulsed electric field waveform manipulation and use |
US20220047326A1 (en) * | 2020-08-13 | 2022-02-17 | Biosense Webster (Israel) Ltd. | Applying Bipolar Ablation Energy Between Shorted Electrode Groups |
US11950841B2 (en) | 2020-09-22 | 2024-04-09 | Biosense Webster (Israel) Ltd. | Basket catheter having insulated ablation electrodes and diagnostic electrodes |
US11950840B2 (en) | 2020-09-22 | 2024-04-09 | Biosense Webster (Israel) Ltd. | Basket catheter having insulated ablation electrodes |
WO2022139797A1 (en) * | 2020-12-21 | 2022-06-30 | Arga' Medtech Sa | Electronic apparatus for delivering coherent sine burst irreversible electroporation energy to a biological tissue |
US11918383B2 (en) | 2020-12-21 | 2024-03-05 | Biosense Webster (Israel) Ltd. | Visualizing performance of catheter electrodes |
JP2024509644A (en) | 2021-04-07 | 2024-03-04 | ビーティーエル メディカル デベロップメント エー.エス. | Pulsed field ablation device and method |
IL309432A (en) | 2021-07-06 | 2024-02-01 | Btl Medical Dev A S | Pulsed field ablation device and method |
WO2023280822A1 (en) * | 2021-07-06 | 2023-01-12 | Btl Medical Technologies S.R.O. | Pulsed field ablation device and method |
US20230052114A1 (en) * | 2021-08-12 | 2023-02-16 | St. Jude Medical, Cardiology Division, Inc. | Systems and methods for electroporation using asymmetric waveforms and waveforms with reduced burst duration |
CN113729918A (en) * | 2021-08-12 | 2021-12-03 | 圣犹达医疗用品心脏病学部门有限公司 | System and method for electroporation using asymmetric waveforms |
US11944374B2 (en) * | 2021-08-30 | 2024-04-02 | Covidien Lp | Electrical signals for retrieval of material from vessel lumens |
CA3233052A1 (en) * | 2021-09-20 | 2023-03-23 | Galvanize Therapeutics, Inc. | Controlled lesion and immune response to pulsed electric field therapy |
CN114271931B (en) * | 2021-12-23 | 2023-09-12 | 心航路医学科技(广州)有限公司 | Pulse ablation system |
CN114259296A (en) * | 2021-12-23 | 2022-04-01 | 心航路医学科技(广州)有限公司 | Pulse electric field generator |
CN114534091B (en) * | 2022-02-17 | 2022-09-09 | 湖南安泰康成生物科技有限公司 | Apparatus for inhibiting tumor proliferation by electric field and control device thereof |
WO2023212250A1 (en) * | 2022-04-28 | 2023-11-02 | Galvanize Therapeutics, Inc. | Lesion optimization in the use of pulsed electric fields |
Family Cites Families (175)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5386837A (en) | 1993-02-01 | 1995-02-07 | Mmtc, Inc. | Method for enhancing delivery of chemotherapy employing high-frequency force fields |
US5993434A (en) | 1993-04-01 | 1999-11-30 | Genetronics, Inc. | Method of treatment using electroporation mediated delivery of drugs and genes |
AUPN957296A0 (en) | 1996-04-30 | 1996-05-23 | Cardiac Crc Nominees Pty Limited | A system for simultaneous unipolar multi-electrode ablation |
SE509241C2 (en) | 1996-07-18 | 1998-12-21 | Radinvent Ab | Devices for electrodynamic radiation therapy of tumor diseases |
US5906609A (en) * | 1997-02-05 | 1999-05-25 | Sahar Technologies | Method for delivering energy within continuous outline |
US6055453A (en) | 1997-08-01 | 2000-04-25 | Genetronics, Inc. | Apparatus for addressing needle array electrodes for electroporation therapy |
US6241701B1 (en) | 1997-08-01 | 2001-06-05 | Genetronics, Inc. | Apparatus for electroporation mediated delivery of drugs and genes |
US6043066A (en) | 1997-09-04 | 2000-03-28 | Mangano; Joseph A. | Cell separation using electric fields |
US6038478A (en) | 1997-10-16 | 2000-03-14 | Huntingdon Medical Research Institutes | Lymphocyte attraction by electrical stimulation |
JP2002508989A (en) | 1998-01-14 | 2002-03-26 | キューロン メディカル,インコーポレイテッド | Electrosurgical instruments and methods for treating gastroesophageal reflux disease (GERD) |
WO1999043263A1 (en) | 1998-02-27 | 1999-09-02 | Conway-Stuart Medical, Inc. | Apparatus to electrosurgically treat esophageal sphincters |
US6107699A (en) * | 1998-05-22 | 2000-08-22 | Scimed Life Systems, Inc. | Power supply for use in electrophysiological apparatus employing high-voltage pulses to render tissue temporarily unresponsive |
JP3819160B2 (en) | 1998-09-18 | 2006-09-06 | 富士通株式会社 | Information management method and information management apparatus |
US6325797B1 (en) * | 1999-04-05 | 2001-12-04 | Medtronic, Inc. | Ablation catheter and method for isolating a pulmonary vein |
US6738663B2 (en) | 1999-04-09 | 2004-05-18 | Oncostim, A Minnesota Corporation | Implantable device and method for the electrical treatment of cancer |
US6366808B1 (en) | 2000-03-13 | 2002-04-02 | Edward A. Schroeppel | Implantable device and method for the electrical treatment of cancer |
US20020010491A1 (en) | 1999-08-04 | 2002-01-24 | Schoenbach Karl H. | Method and apparatus for intracellular electro-manipulation |
US6326177B1 (en) | 1999-08-04 | 2001-12-04 | Eastern Virginia Medical School Of The Medical College Of Hampton Roads | Method and apparatus for intracellular electro-manipulation |
US7113821B1 (en) | 1999-08-25 | 2006-09-26 | Johnson & Johnson Consumer Companies, Inc. | Tissue electroperforation for enhanced drug delivery |
US6689062B1 (en) | 1999-11-23 | 2004-02-10 | Microaccess Medical Systems, Inc. | Method and apparatus for transesophageal cardiovascular procedures |
US8175698B2 (en) | 2000-02-17 | 2012-05-08 | Novocure Ltd. | Treating bacteria with electric fields |
US7599746B2 (en) | 2000-02-17 | 2009-10-06 | Standen Ltd | Apparatus and method for preventing the spread of cancerous metastases and for elimination of metastases |
US7742811B2 (en) | 2000-03-13 | 2010-06-22 | Onco Stim | Implantable device and method for the electrical treatment of cancer |
US8024048B2 (en) | 2000-03-13 | 2011-09-20 | Ionix Medical Inc. | Method and device for treating cancer with electrical therapy in conjunction with chemotherapeutic agents and radiation therapy |
US6733485B1 (en) | 2001-05-25 | 2004-05-11 | Advanced Bionics Corporation | Microstimulator-based electrochemotherapy methods and systems |
US20020198567A1 (en) | 2001-06-07 | 2002-12-26 | Yona Keisari | Electro-endocytotic therapy as a treatment modality of cancer |
US7130697B2 (en) | 2002-08-13 | 2006-10-31 | Minnesota Medical Physics Llc | Apparatus and method for the treatment of benign prostatic hyperplasia |
US6994706B2 (en) | 2001-08-13 | 2006-02-07 | Minnesota Medical Physics, Llc | Apparatus and method for treatment of benign prostatic hyperplasia |
USRE42016E1 (en) | 2001-08-13 | 2010-12-28 | Angiodynamics, Inc. | Apparatus and method for the treatment of benign prostatic hyperplasia |
US7713740B2 (en) | 2001-08-24 | 2010-05-11 | University Of South Florida | Method of using electric fields to facilitate the entry of molecules into cells in vivo |
US7879610B1 (en) | 2001-08-24 | 2011-02-01 | University Of South Florida | Electroporation system and method for facilitating entry of molecules into cells in vivo |
WO2003047684A2 (en) | 2001-12-04 | 2003-06-12 | University Of Southern California | Method for intracellular modifications within living cells using pulsed electric fields |
US7620451B2 (en) * | 2005-12-29 | 2009-11-17 | Ardian, Inc. | Methods and apparatus for pulsed electric field neuromodulation via an intra-to-extravascular approach |
US8347891B2 (en) * | 2002-04-08 | 2013-01-08 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen |
WO2004037341A2 (en) | 2002-05-07 | 2004-05-06 | Schroeppel Edward A | Method and device for treating concer with electrical therapy in conjunction with chemotherapeutic agents and radiation therapy |
US20040044338A1 (en) | 2002-08-30 | 2004-03-04 | Lennox Arlene J. | Methods and systems for administering microcurrent therapy for treatment and prevention of side effects associated with cancer treatment |
US7258690B2 (en) | 2003-03-28 | 2007-08-21 | Relievant Medsystems, Inc. | Windowed thermal ablation probe |
AU2004247071B2 (en) | 2003-05-30 | 2010-03-11 | University Of South Florida | Method for the treatment of malignancies |
US8802643B1 (en) | 2003-05-30 | 2014-08-12 | University Of South Florida | Method for the treatment of malignancies |
US20060269531A1 (en) | 2003-07-18 | 2006-11-30 | Eastern Virginia Medical School | Apparatus for generating electrical pulses and methods of using the same |
DE202004021943U1 (en) * | 2003-09-12 | 2013-05-13 | Vessix Vascular, Inc. | Selectable eccentric remodeling and / or ablation of atherosclerotic material |
US8500713B2 (en) | 2003-10-29 | 2013-08-06 | Medtronic, Inc. | Implantable electroporation therapy device and method for using same |
ES2729378T3 (en) | 2003-12-24 | 2019-11-04 | Univ California | Tissue ablation with irreversible electroporation |
US8298222B2 (en) | 2003-12-24 | 2012-10-30 | The Regents Of The University Of California | Electroporation to deliver chemotherapeutics and enhance tumor regression |
US20050222646A1 (en) | 2004-04-06 | 2005-10-06 | Kai Kroll | Method and device for treating cancer with modified output electrical therapy |
US8244345B2 (en) | 2004-04-23 | 2012-08-14 | Novocure Ltd | Treating a tumor or the like with electric fields at different frequencies |
AU2005289828A1 (en) | 2004-09-24 | 2006-04-06 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and devices for the non-thermal, electrically-induced closure of blood vessels |
JP5559460B2 (en) | 2004-12-27 | 2014-07-23 | スタンデン・リミテッド | Method for treating tumors or the like using electric fields of different orientations |
US20120226271A1 (en) | 2005-03-25 | 2012-09-06 | Peter Callas | Vacuum Ablation Apparatus and Method |
US20060264752A1 (en) | 2005-04-27 | 2006-11-23 | The Regents Of The University Of California | Electroporation controlled with real time imaging |
US8114070B2 (en) | 2005-06-24 | 2012-02-14 | Angiodynamics, Inc. | Methods and systems for treating BPH using electroporation |
US20060293731A1 (en) | 2005-06-24 | 2006-12-28 | Boris Rubinsky | Methods and systems for treating tumors using electroporation |
US20070021803A1 (en) | 2005-07-22 | 2007-01-25 | The Foundry Inc. | Systems and methods for neuromodulation for treatment of pain and other disorders associated with nerve conduction |
US7608275B2 (en) * | 2005-07-22 | 2009-10-27 | The Foundry, Llc | Systems and methods for delivery of a therapeutic agent |
DK1933937T3 (en) | 2005-10-03 | 2015-04-07 | Novocure Ltd | OPTIMIZATION OF THE CHARACTERISTICS OF AN ELECTRIC FIELD FOR ENHANCING FIELD EFFECT ON proliferating cells |
US20070191904A1 (en) | 2006-02-14 | 2007-08-16 | Imad Libbus | Expandable stimulation electrode with integrated pressure sensor and methods related thereto |
WO2007100727A2 (en) | 2006-02-24 | 2007-09-07 | Eastern Virginia Medical School | Nanosecond pulsed electric fields cause melanomas to self-destruct |
US9037230B2 (en) | 2006-03-03 | 2015-05-19 | Oncosec Medical Incorporated | Method and device for treating microscopic tumors remaining in tissues following surgical resection |
US8019414B2 (en) | 2006-04-05 | 2011-09-13 | Novocure Ltd. | Treating cancer using electromagnetic fields in combination with other treatment regimens |
JP5457183B2 (en) | 2006-09-14 | 2014-04-02 | ラジュール・テクノロジーズ・エルエルシイ | Apparatus and method for destroying cancer cells |
US7691080B2 (en) | 2006-09-21 | 2010-04-06 | Mercator Medsystems, Inc. | Dual modulus balloon for interventional procedures |
US8983609B2 (en) | 2007-05-30 | 2015-03-17 | The Cleveland Clinic Foundation | Apparatus and method for treating pulmonary conditions |
WO2009121017A1 (en) * | 2008-03-27 | 2009-10-01 | The Regents Of The University Of California | Balloon catheter for reducing restenosis via irreversible electroporation |
US10448989B2 (en) | 2009-04-09 | 2019-10-22 | Virginia Tech Intellectual Properties, Inc. | High-frequency electroporation for cancer therapy |
US8926606B2 (en) | 2009-04-09 | 2015-01-06 | Virginia Tech Intellectual Properties, Inc. | Integration of very short electric pulses for minimally to noninvasive electroporation |
US8992517B2 (en) | 2008-04-29 | 2015-03-31 | Virginia Tech Intellectual Properties Inc. | Irreversible electroporation to treat aberrant cell masses |
US10245098B2 (en) | 2008-04-29 | 2019-04-02 | Virginia Tech Intellectual Properties, Inc. | Acute blood-brain barrier disruption using electrical energy based therapy |
WO2009137800A2 (en) | 2008-05-09 | 2009-11-12 | Angiodynamics, Inc. | Electroporation device and method |
WO2009137819A1 (en) | 2008-05-09 | 2009-11-12 | Innovative Pulmonary Solutions, Inc. | Systems, assemblies, and methods for treating a bronchial tree |
US10736689B2 (en) | 2008-08-20 | 2020-08-11 | Prostacare Pty Ltd | Low-corrosion electrode for treating tissue |
WO2010022275A1 (en) | 2008-08-20 | 2010-02-25 | Ionix Medical, Inc. | Non-thermal ablation system for treating tissue |
US8361066B2 (en) | 2009-01-12 | 2013-01-29 | Ethicon Endo-Surgery, Inc. | Electrical ablation devices |
US8231603B2 (en) | 2009-02-10 | 2012-07-31 | Angiodynamics, Inc. | Irreversible electroporation and tissue regeneration |
US20100228248A1 (en) | 2009-03-03 | 2010-09-09 | Griffin Adam H | Method and device for treating cancer with electrical therapy in conjunction with a catheter and high power pulser |
WO2010107947A1 (en) | 2009-03-17 | 2010-09-23 | Bioelectromed Corp. | Nanosecond pulsed electric field parameters for destroying tumors with a single treatment |
US20100240995A1 (en) | 2009-03-17 | 2010-09-23 | Bioelectromed Corp. | System and method for treating tumors |
US8512334B2 (en) | 2009-06-12 | 2013-08-20 | Bioelectromed Corporation | Nanosecond pulsed electric field parameters for destroying tumors with a single treatment |
US20100256630A1 (en) | 2009-04-07 | 2010-10-07 | Angiodynamics, Inc. | Irreversible electroporation (ire) for esophageal disease |
US11638603B2 (en) | 2009-04-09 | 2023-05-02 | Virginia Tech Intellectual Properties, Inc. | Selective modulation of intracellular effects of cells using pulsed electric fields |
US11382681B2 (en) | 2009-04-09 | 2022-07-12 | Virginia Tech Intellectual Properties, Inc. | Device and methods for delivery of high frequency electrical pulses for non-thermal ablation |
US9339328B2 (en) | 2009-08-20 | 2016-05-17 | Angiodynamics, Inc. | Multi-electrode energy delivery device and method of using the same |
WO2011056684A2 (en) | 2009-10-27 | 2011-05-12 | Innovative Pulmonary Solutions, Inc. | Delivery devices with coolable energy emitting assemblies |
US20170049513A1 (en) | 2009-11-06 | 2017-02-23 | Cosman Medical, Inc. | Multiple electrode generator |
US20110118732A1 (en) | 2009-11-19 | 2011-05-19 | The Regents Of The University Of California | Controlled irreversible electroporation |
US20110160514A1 (en) | 2009-12-31 | 2011-06-30 | Ethicon Endo-Surgery, Inc. | Electrical ablation devices |
US20110202052A1 (en) | 2010-02-12 | 2011-08-18 | Daniel Gelbart | System for treating benign prostatic hyperplasia |
US20110288545A1 (en) | 2010-04-22 | 2011-11-24 | Old Dominion University Research Foundation | Method and Device for Ablation of Cancer and Resistance to New Cancer Growth |
GB201006841D0 (en) | 2010-04-26 | 2010-06-09 | Thomsen Lars | Method, device and system for targetted cell lysis |
MX2013004437A (en) | 2010-10-25 | 2013-07-17 | Medtronic Ardian Luxembourg | Catheter apparatuses having multi-electrode arrays for renal neuromodulation and associated systems and methods. |
US9044245B2 (en) | 2011-01-05 | 2015-06-02 | Medtronic Ablation Frontiers Llc | Multipolarity epicardial radiofrequency ablation |
US9314620B2 (en) | 2011-02-28 | 2016-04-19 | Ethicon Endo-Surgery, Inc. | Electrical ablation devices and methods |
US9233241B2 (en) | 2011-02-28 | 2016-01-12 | Ethicon Endo-Surgery, Inc. | Electrical ablation devices and methods |
WO2012120495A2 (en) | 2011-03-04 | 2012-09-13 | Rainbow Medical Ltd. | Tissue treatment and monitoring by application of energy |
US10722282B2 (en) | 2011-06-14 | 2020-07-28 | Aerin Medical, Inc. | Methods and devices to treat nasal airways |
US20130030430A1 (en) | 2011-07-29 | 2013-01-31 | Stewart Mark T | Intracardiac tools and methods for delivery of electroporation therapies |
US9387031B2 (en) * | 2011-07-29 | 2016-07-12 | Medtronic Ablation Frontiers Llc | Mesh-overlayed ablation and mapping device |
US9351790B2 (en) | 2011-09-17 | 2016-05-31 | M.O.E. Medical Devices Llc | Electrode geometries and method for applying electric field treatment to parts of the body |
US10470684B2 (en) | 2012-01-26 | 2019-11-12 | Autonomix Medical, Inc. | Controlled sympathectomy and micro-ablation systems and methods |
US20130218143A1 (en) * | 2012-02-20 | 2013-08-22 | Tyco Healthcare Group Lp | Combined Thermal Therapy and Hydrogel with Embedded Stem Cell Treatment |
US10314649B2 (en) | 2012-08-02 | 2019-06-11 | Ethicon Endo-Surgery, Inc. | Flexible expandable electrode and method of intraluminal delivery of pulsed power |
US20160000499A1 (en) | 2013-03-15 | 2016-01-07 | Cibiem, Inc. | Endovascular catheters for carotid body ablation utilizing an ionic liquid stream |
US10779875B2 (en) | 2013-05-06 | 2020-09-22 | Novocure Gmbh | Optimizing treatment using TTfields by changing the frequency during the course of long term tumor treatment |
US9655669B2 (en) | 2013-05-06 | 2017-05-23 | Novocure Limited | Optimizing treatment using TTFields by changing the frequency during the course of long term tumor treatment |
CA2914195C (en) | 2013-06-03 | 2020-06-02 | Nanoblate Corporation | Methods and devices for stimulating an immune response using nanosecond pulsed electric fields |
AU2014274903B2 (en) | 2013-06-05 | 2019-03-07 | Medtronic Ireland Manufacturing Unlimited Company | Modulation of targeted nerve fibers |
US9242041B2 (en) | 2013-06-17 | 2016-01-26 | Quantum Cure, Inc. | Method and apparatus for cancer treatment |
US10154869B2 (en) | 2013-08-02 | 2018-12-18 | Gary M. Onik | System and method for creating radio-frequency energy electrical membrane breakdown for tissue ablation |
US10478247B2 (en) | 2013-08-09 | 2019-11-19 | Boston Scientific Scimed, Inc. | Expandable catheter and related methods of manufacture and use |
WO2015042173A1 (en) * | 2013-09-20 | 2015-03-26 | Advanced Cardiac Therapeutics, Inc. | Temperature sensing and tissue ablation using a plurality of electrodes |
US9763733B2 (en) | 2013-10-25 | 2017-09-19 | Covidien Lp | Unfurling electrode devices with the multiple longitudinal electrode segments |
CN105792883B (en) | 2013-12-05 | 2019-11-05 | 飞慕控股有限责任公司 | Utilize the immunotherapy for cancer of radio frequency electricity film breakdown (RF-EMB) |
US20150289923A1 (en) | 2014-04-14 | 2015-10-15 | Virginia Tech Intellectual Properties, Inc. | Treatment planning for electrical-energy based therapies based on cell characteristics |
AU2015259303B2 (en) | 2014-05-12 | 2021-10-28 | Arena, Christopher B. | Selective modulation of intracellular effects of cells using pulsed electric fields |
US20150342669A1 (en) | 2014-05-29 | 2015-12-03 | Boston Scientific Scimed, Inc. | Devices and methods for controlled energy delivery to airways |
WO2015192027A1 (en) | 2014-06-12 | 2015-12-17 | Iowa Approach Inc. | Method and apparatus for rapid and selective transurethral tissue ablation |
US9833617B2 (en) | 2014-07-25 | 2017-12-05 | Loyalty Based Innovations, LLC | Apparatus and method for treating multiple tumors in patients with metastatic disease by electric fields |
US20190117963A1 (en) | 2014-07-25 | 2019-04-25 | Loyalty Based Innovations, LLC | Apparatus and method for treating multiple tumors in patients with metastatic disease by electric fields |
WO2016036891A1 (en) | 2014-09-02 | 2016-03-10 | Old Dominion University | Electromanipulation of proteins using nanosecond pulsed electric fields |
WO2016089781A1 (en) | 2014-12-01 | 2016-06-09 | Electroblate, Inc. | Nanoelectroablation control and vaccination |
US10271893B2 (en) * | 2014-12-15 | 2019-04-30 | Medtronic Ablation Frontiers Llc | Timed energy delivery |
ES2809734T3 (en) | 2015-01-09 | 2021-03-05 | Oncosec Medical Inc | Gene therapy and electroporation for the treatment of malignant neoplasms |
EP3250142A4 (en) | 2015-01-30 | 2018-11-21 | Rfemb Holdings LLC | Radio-frequency electrical membrane breakdown for the treatment of tissues |
CA2975926A1 (en) | 2015-02-04 | 2016-08-11 | Rfemb Holdings, Llc | Radio-frequency electrical membrane breakdown for the treatment of benign prostatic hyperplasia |
US20180110978A1 (en) | 2015-03-19 | 2018-04-26 | Old Dominion University Research Foundation | Synergistic regulated cell death induction with hsp90 inhibitors and nanosecond pulsed electric fields |
JP6879996B2 (en) | 2015-03-26 | 2021-06-02 | オンコセック メディカル インコーポレイテッド | How to treat malignant tumors |
AU2016246146B2 (en) | 2015-04-10 | 2021-03-11 | Angiodynamics, Inc. | System and method for irreversible electroporation with thermally controlled electrodes |
CN108472071B (en) | 2015-05-01 | 2021-03-16 | 因特科学股份有限公司 | Methods, systems, and apparatus for tissue ablation using pulse shape design |
CA2985847C (en) | 2015-05-14 | 2022-11-08 | London Health Sciences Centre Research Inc. | Intratumoral modulation therapy |
WO2016201264A1 (en) | 2015-06-11 | 2016-12-15 | Massachusetts Institute Of Technology | Methods for inducing electroporation and tissue ablation |
CN108601883A (en) | 2015-09-29 | 2018-09-28 | 埃吉诺维亚公司 | Delivering method and composition |
WO2017066651A1 (en) | 2015-10-14 | 2017-04-20 | Zarembinski Chris | Integrated needle-catheter systems and methods of use |
US20170105793A1 (en) * | 2015-10-15 | 2017-04-20 | Boston Scientific Scimed, Inc. | Energy delivery devices and related methods of use |
US10172673B2 (en) | 2016-01-05 | 2019-01-08 | Farapulse, Inc. | Systems devices, and methods for delivery of pulsed electric field ablative energy to endocardial tissue |
WO2017120169A1 (en) * | 2016-01-05 | 2017-07-13 | Iowa Approach, Inc. | Systems, devices, and methods for delivery of pulsed electric field ablative energy to endocardial tissue |
US20170189097A1 (en) | 2016-01-05 | 2017-07-06 | Iowa Approach Inc. | Systems, apparatuses and methods for delivery of ablative energy to tissue |
WO2017173089A1 (en) | 2016-03-31 | 2017-10-05 | Memorial Sloan Kettering Cancer Center | Systems and methods for enhancing delivery of diagnostic and/or therapeutic compositions in vivo using electric pulses |
US10821283B2 (en) | 2016-04-04 | 2020-11-03 | Novocure Gmbh | Reducing motility of cancer cells using tumor treating fields (TTFields) |
EP4209190A1 (en) | 2016-06-27 | 2023-07-12 | Galvanize Therapeutics, Inc. | System comprising a generator and a catheter with an electrode for treating a lung passageway |
US20210236815A1 (en) | 2016-06-27 | 2021-08-05 | Galary, Inc. | Immunostimulation in the treatment of viral infection |
CN106388932B (en) | 2016-07-12 | 2017-10-10 | 上海睿刀医疗科技有限公司 | Irreversible electroporation device |
WO2018065806A1 (en) | 2016-10-06 | 2018-04-12 | Consejo Nacional De Investigaciones Cientificas Y Tecnicas (Conicet) | Single-needle device for the treatment of deep tumours by means of electrochemotherapy |
US20200046967A1 (en) | 2016-10-06 | 2020-02-13 | Virginia Tech Intellectual Properties, Inc. | Induced cell morphology electroporation |
US20180104486A1 (en) | 2016-10-18 | 2018-04-19 | Korea University Research And Business Foundation | Apparatus and method for treating cancer using discontinuous fractional alternative electric field |
EP3528730A1 (en) | 2016-10-20 | 2019-08-28 | Old Dominion University Research Foundation | Methods and devices for using sub-microsecond electric pulses to trigger apoptosis |
US10905492B2 (en) | 2016-11-17 | 2021-02-02 | Angiodynamics, Inc. | Techniques for irreversible electroporation using a single-pole tine-style internal device communicating with an external surface electrode |
US20180154142A1 (en) | 2016-12-05 | 2018-06-07 | Old Dominion University Research Foundation | Methods and devices for treatment of tumors with nano-pulse stimulation |
US11229478B2 (en) | 2017-02-08 | 2022-01-25 | Medtronic, Inc. | Profile parameter selection algorithm for electroporation |
CN107194119B (en) * | 2017-06-20 | 2020-10-27 | 北京盖乐照明设计有限公司 | Method for determining shape parameters of fixed sunshade plate net |
US10850095B2 (en) | 2017-08-08 | 2020-12-01 | Pulse Biosciences, Inc. | Treatment of tissue by the application of energy |
EP3459480A1 (en) | 2017-09-21 | 2019-03-27 | National University of Ireland, Galway | Apparatus for localising an electrical field |
US20190117969A1 (en) | 2017-10-23 | 2019-04-25 | Cardiac Pacemakers, Inc. | Medical devices for treatment of cancer with electric fields |
CN107714171A (en) | 2017-11-16 | 2018-02-23 | 中国人民解放军火箭军总医院 | A kind of Pulsed Electric Fields therapeutic apparatus for treating tumor |
CN112543661A (en) | 2017-11-17 | 2021-03-23 | 艾伯维公司 | Methods of treating glioblastoma |
US20190160283A1 (en) | 2017-11-28 | 2019-05-30 | Pulse Biosciences, Inc. | Methods and devices for treating hpv-associated lesions using nanosecond pulsed electric fields |
US11607537B2 (en) | 2017-12-05 | 2023-03-21 | Virginia Tech Intellectual Properties, Inc. | Method for treating neurological disorders, including tumors, with electroporation |
EP4218640A1 (en) | 2017-12-26 | 2023-08-02 | Galvanize Therapeutics, Inc. | Systems for the treatment of disease states and disorders |
WO2019133608A1 (en) | 2017-12-26 | 2019-07-04 | Gala Therapeutics, Inc. | Optimization of energy delivery for various applications |
EP3742998B1 (en) | 2018-01-23 | 2023-11-15 | Boston Scientific Scimed, Inc. | Enhanced needle array and therapies for tumor ablation |
WO2019164650A1 (en) | 2018-02-21 | 2019-08-29 | Medtronic, Inc. | Focal pulsed field ablation devices and methods |
US11311329B2 (en) | 2018-03-13 | 2022-04-26 | Virginia Tech Intellectual Properties, Inc. | Treatment planning for immunotherapy based treatments using non-thermal ablation techniques |
CN117757842A (en) | 2018-03-15 | 2024-03-26 | 星际治疗有限公司 | Synthetic DNA carriers and methods of use |
US11712576B2 (en) | 2018-03-29 | 2023-08-01 | Minnesota Medical Physics Llc | Method and apparatus for cancer treatment |
US11298422B2 (en) | 2018-04-09 | 2022-04-12 | Novocure Gmbh | Treating tumors with TTFields and an aurora kinase inhibitor |
CN116159242A (en) | 2018-07-03 | 2023-05-26 | 埃德温·阊 | Enhancement of cell membrane permeability using alternating electric fields |
US11179322B2 (en) | 2018-07-10 | 2021-11-23 | Novocure Gmbh | Methods and compositions for treating tumors with TTFields and sorafenib |
CN112423836A (en) | 2018-07-17 | 2021-02-26 | 迪格尼提健康公司 | System and method for treating cancer using alternating electric field generation |
US20220387095A1 (en) | 2019-04-18 | 2022-12-08 | Galvanize Therapeutics, Inc. | Applying pulsed electric fields in the treatment of neural disorders |
JP2022529058A (en) | 2019-04-18 | 2022-06-16 | ギャラリー,インコーポレイテッド | Instruments and systems for treating abnormal tissue, |
CA3147592A1 (en) | 2019-07-16 | 2021-01-21 | Galary, Inc. | Treatment of the reproductive tract with pulsed electric fields |
US20210023362A1 (en) | 2019-07-24 | 2021-01-28 | Virginia Tech Intellectual Properties, Inc. | Fourier analysis spectroscopy for monitoring tissue impedance changes and treatment outcome during electroporation-based-therapies |
JP2023509387A (en) | 2019-12-18 | 2023-03-08 | ガルヴァナイズ セラピューティクス,インコーポレイテッド | Treatment of cardiac tissue with pulsed electric fields |
WO2021207385A1 (en) | 2020-04-08 | 2021-10-14 | Galary, Inc. | Pulsed electric field waveform manipulation and use |
CN116829691A (en) | 2020-08-04 | 2023-09-29 | 盖能适治疗股份有限公司 | Pulsed electric field transfer of molecules to cells in vivo |
WO2022031797A1 (en) | 2020-08-04 | 2022-02-10 | Galary, Inc. | Pulsed electric field transfer of molecules to cells while in the body |
CA3214778A1 (en) | 2021-03-25 | 2022-09-29 | Galvanize Therapeutics, Inc. | Multi-electrode system and method for deducing treatment effect outcomes |
-
2018
- 2018-12-26 WO PCT/US2018/067504 patent/WO2019133608A1/en unknown
- 2018-12-26 CN CN201880088682.2A patent/CN111683613A/en active Pending
- 2018-12-26 EP EP23178276.4A patent/EP4218641A1/en active Pending
- 2018-12-26 CA CA3087183A patent/CA3087183A1/en active Pending
- 2018-12-26 AU AU2018397478A patent/AU2018397478A1/en active Pending
- 2018-12-26 DK DK18836576.1T patent/DK3731771T3/en active
- 2018-12-26 EP EP18836576.1A patent/EP3731771B1/en active Active
- 2018-12-26 JP JP2020535579A patent/JP2021508533A/en active Pending
-
2020
- 2020-06-26 US US16/914,200 patent/US11547851B2/en active Active
-
2022
- 2022-12-07 US US18/077,097 patent/US11938317B2/en active Active
-
2023
- 2023-08-24 JP JP2023135986A patent/JP2023168331A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPWO2019133608A5 (en) | ||
US11938317B2 (en) | Optimization of energy delivery for various applications | |
US20240065760A1 (en) | Cardiac pulsed field ablation | |
JP7442076B2 (en) | Systems, devices, and methods for delivering pulsed electric field ablation energy to endocardial tissue | |
US11633230B2 (en) | Intracardiac tools and methods for delivery of electroporation therapies | |
US9113911B2 (en) | Ablation device and method for electroporating tissue cells | |
US20210393327A1 (en) | Treatment of cardiac tissue with pulsed electric fields | |
EP3578124A1 (en) | Electrophysiology apparatus | |
Di Biase et al. | Pulsed field catheter ablation in atrial fibrillation | |
JP2022067039A (en) | Using unipolar configuration for irreversible electroporation (ire) | |
US20220008123A1 (en) | Sequential activation of electrode-pairs during irreversible electroporation (ire) | |
CZ33133U1 (en) | Electroporation generator for cardiac tissue ablation | |
IL309363A (en) | Electroporation treatment | |
Naccarelli et al. | Catheter ablation of canine ventricular myocardium utilizing radiofrequency current | |
US20220346857A1 (en) | Tissue ablation using high-frequency unipolar ire | |
US20230089295A1 (en) | Combined electrodes for tissue penetrative irreversible electroporation (ire) | |
US20230310061A1 (en) | Multiple pulse width trains to enhance ablation homogeneity in highly oriented cellular substrates | |
CN117426863A (en) | Tissue ablation using high frequency monopole IRE | |
Marcus | Radiofrequency Energy for Catheter Ablative Procedures | |
Wagshal et al. | Application of radiofrequency energy as an energy source for ablation of cardiac arrhythmias | |
CA3212976A1 (en) | Devices for the delivery of pulsed electric fields in the treatment of cardiac tissue |